Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 453, 604-605 (29 May 2008) | doi:10.1038/453604a; Published online 28 May 2008
Open Innovation Challenges
- More Challenges
- Powered by:
nature jobs
Group Leader Positions
- IMP
- Vienna Austria
Assistant Professor and Associate Professor
- Massachusetts General Hospital/ Harvard Medical School
- Charlestown, MA
Cancer: Whispering sweet somethings
Thea Tlsty1
Abstract
That genetic mutations contribute to cancer is undisputed. What now emerges is that a cancer cell's microenvironment has a much stronger hand in the course a cancer takes than previously thought.
The goal of personalized medicine is to tailor a treatment to a specific cellular target at the appropriate stage of a disease, thus 'defusing' the disease process. Cancer is an example of the way in which multifaceted approaches to attaining this goal are emerging.
- Thea Tlsty is in the Department of Pathology, University of California, San Francisco, 513 Parnassus Avenue, San Francisco, California 94143-0511, USA.
Email: thea.tlsty@ucsf.edu
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Stromal gene expression predicts clinical outcome in breast cancerNature Medicine Article (01 May 2008)
Stromal signature identifies basal breast cancersNature Medicine Correspondence (01 Mar 2009)
